These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
☒
|
Filed by the Registrant
|
☐
|
Filed by a party other than the Registrant
|
|
CHECK THE APPROPRIATE BOX:
|
|
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☒
|
Definitive Proxy Statement
|
|
☐
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material under §240.14a-12
|
|
Payment of Filing Fee (Check all boxes that apply):
|
|
|
☒
|
No fee required
|
|
☐
|
Fee paid previously with preliminary materials
|
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
|
May 9, 2025
|
||
|
Gregory W. Haskell
Chief Executive Officer and Director
|
|
Date and Time:
|
June 25, 2025
9:00 a.m. Eastern Time
|
|
|
Record Date:
|
April 28, 2025
|
You may vote if you were a stockholder at the close
of business on April 28, 2025. A list of stockholders
as of the close of business on the Record Date will be
available for examination by stockholders during the
Annual Meeting and for a period of 10 days prior to
the Annual Meeting. If you would like to view the
stockholder list in advance of the Annual Meeting,
please contact us at
investorrelations@innventure.com to schedule an
appointment and make arrangements.
|
|
Place:
|
www.virtualshareholdermeeting.com/
INV2025
|
|
|
Proxy Mail Date:
|
May 9, 2025
|
|
Internet
www.proxyvote.com
|
Mail
mark, sign, date & return your proxy card
|
|
|
Phone
1-800-690-6903
|
Live at the virtual Annual Meeting
www.virtualshareholdermeeting.com/INV2025
|
|
By order of the Board of Directors,
|
||
|
Suzanne Niemeyer
General Counsel
|
|
Page
|
|
|
GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING
.......................................................
|
|
|
PROPOSAL ONE—ELECTION OF DIRECTORS
...........................................................................................................
|
|
|
Board Recommendation
...............................................................................................................................................
|
|
|
CORPORATE GOVERNANCE
.........................................................................................................................................
|
|
|
Our Board of Directors
.................................................................................................................................................
|
|
|
Our Executive Officers
.................................................................................................................................................
|
|
|
Governance Overview
..................................................................................................................................................
|
|
|
Board Composition
......................................................................................................................................................
|
|
|
Director Independence
.................................................................................................................................................
|
|
|
Director Nominations
...................................................................................................................................................
|
|
|
Board Leadership Structure
..........................................................................................................................................
|
|
|
Board’s Role in Risk Oversight
...................................................................................................................................
|
|
|
Board Committees
........................................................................................................................................................
|
|
|
Executive Sessions
.......................................................................................................................................................
|
|
|
Director Meeting Attendance
.......................................................................................................................................
|
|
|
Stockholder Communications with the Board
..............................................................................................................
|
|
|
Code of Business Conduct and Ethics
..........................................................................................................................
|
|
|
Corporate Governance Guidelines
...............................................................................................................................
|
|
|
Compensation Clawback Policy
...................................................................................................................................
|
|
|
Insider Trading and Anti-Hedging Policies and Procedures
........................................................................................
|
|
|
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
..................................................................
|
|
|
Transactions with AeroFlexx, Accelsius, Innventus ESG Fund I, L.P., and Innventure1, LLC
..................................
|
|
|
AeroFlexx
.....................................................................................................................................................................
|
|
|
Accelsius
......................................................................................................................................................................
|
|
|
Other Related Party Transactions
.................................................................................................................................
|
|
|
Review, Approval or Ratification of Transactions with Related Parties
.....................................................................
|
|
|
Limitation of Liability and Indemnification of Directors and Executive Officers
.......................................................
|
|
|
Related Party Transaction Policy
.................................................................................................................................
|
|
|
FIRM FOR THE FISCAL YEAR ENDING DECEMBER 21, 2025
..........................................................................
|
|
|
Board Recommendation
...............................................................................................................................................
|
|
|
Vote Required
..............................................................................................................................................................
|
|
|
Audit Matters
................................................................................................................................................................
|
|
|
Change in Auditor
........................................................................................................................................................
|
|
|
Report of the Audit Committee of the Board
...............................................................................................................
|
|
|
PROPOSAL THREE—SEPA SHARE ISSUANCE PROPOSAL
.....................................................................................
|
|
|
Background
..................................................................................................................................................................
|
|
|
Reasons for Seeking Stockholder Approval
.................................................................................................................
|
|
|
Page
|
|
|
Effect on Current Stockholders
....................................................................................................................................
|
|
|
Consequences of Non-Approval
..................................................................................................................................
|
|
|
Board Recommendation
...............................................................................................................................................
|
|
|
Vote Required
..............................................................................................................................................................
|
|
|
PROPOSAL FOUR—CONVERTIBLE DEBENTURES SHARE ISSUANCE PROPOSAL
..........................................
|
|
|
Background
..................................................................................................................................................................
|
|
|
Reasons for Seeking Stockholder Approval
.................................................................................................................
|
|
|
Effect on Current Stockholders
....................................................................................................................................
|
|
|
Consequences of Non-Approval
..................................................................................................................................
|
|
|
Board Recommendation
...............................................................................................................................................
|
|
|
Vote Required
..............................................................................................................................................................
|
|
|
EXECUTIVE AND DIRECTOR COMPENSATION
........................................................................................................
|
|
|
2024 Business Combination
.........................................................................................................................................
|
|
|
2024 Summary Compensation Table
...........................................................................................................................
|
|
|
Outstanding Equity Awards at 2024 Fiscal Year-End
.................................................................................................
|
|
|
Additional Narrative Disclosure
...................................................................................................................................
|
|
|
Director Compensation
................................................................................................................................................
|
|
|
2024 Director Compensation
.......................................................................................................................................
|
|
|
STOCK OWNERSHIP
........................................................................................................................................................
|
|
|
Stock Ownership of Major Stockholders, Executive Officers and Directors
...............................................................
|
|
|
Securities Authorized for Issuance Under Equity Compensation Plans
......................................................................
|
|
|
OTHER INFORMATION
...................................................................................................................................................
|
|
|
Proxy Materials
............................................................................................................................................................
|
|
|
Delivery of Proxy Materials to Households
.................................................................................................................
|
|
|
Proposal 1:
|
Elect
three Class I directors, Gregory W. Haskell, Daniel J. Hennessy and Michael
Amalfitano, as recommended by the N&CG Committee, each being nominated to
serve for a three-year term expiring at the 2028 annual meeting of stockholders;
|
|
Proposal 2:
|
Ratify
the appointment of BDO USA, P.C. as our independent registered public
accounting firm for the fiscal year ending December 31, 2025;
|
|
Proposal 3:
|
Approve
the issuance of 20% or more of the Company’s issued and outstanding
common stock as of October 2, 2024, pursuant to the SEPA with Yorkville;
|
|
Proposal 4:
|
Approve
issuance of 20% or more of the Company’s issued and outstanding
common stock as of March 25, 2025, pursuant to the Convertible Debentures with
Yorkville; and
|
|
Proposal 5:
|
Transact
any other business that may properly come before the Annual Meeting or
any adjournment or postponement thereof.
|
|
FOR
|
the election of the three nominees to serve as Class I directors on our Board of
Directors, each for a three-year term expiring at the 2028 annual meeting of
stockholders;
|
|
FOR
|
the ratification of the appointment of BDO USA, P.C. as our independent registered
public accounting firm for the fiscal year ending December 31, 2025;
|
|
FOR
|
the issuance of 20% or more of the Company’s issued and outstanding Common
Stock as of October 2, 2024, pursuant to the SEPA with Yorkville; and
|
|
FOR
|
the issuance of 20% or more of the Company’s issued and outstanding Common
Stock as of March 25, 2025, pursuant to the Convertible Debentures with Yorkville.
|
|
Committee Assignments
|
|||||||||||||||||
|
Donnally
|
Brown
|
Williams
|
Hennessy
|
Amalfitano
|
Haskell*
|
Yablunosky*
|
Otworth*
|
Niemeyer*
|
|||||||||
|
Audit
........................
|
C
|
X
|
X
|
||||||||||||||
|
Compensation
.........
|
X
|
C
|
X
|
||||||||||||||
|
Nominating &
Corporate
Governance
........
|
X
|
X
|
C
|
||||||||||||||
|
Audit Committee
|
|
|
Chair:
|
James O. Donnally
|
|
Members:
|
Elizabeth Williams and Dan Hennessy
|
|
Meetings Held in 2024:
|
2
|
|
Committee Description and Responsibilities:
|
|
|
The Audit Committee assists the Board in fulfilling its legal and fiduciary obligations to oversee various matters
involving the Company’s accounting and financial reporting process, auditing functions, financial policies, and legal
and regulatory compliance functions. The Audit Committee is responsible for approving the services performed by our
independent registered public accounting firm and reviewing their reports regarding our accounting practices and
systems of internal accounting controls. The Audit Committee is also responsible for overseeing the audit efforts of our
independent registered public accounting firm and taking action as it deems necessary to establish that the independent
registered public accounting firm is independent of management. Other responsibilities of the Audit Committee include
the preparation, presentation and integrity of the Company’s financial statements, determining the appropriateness of
the accounting and reporting polices used by the Company, and oversight of the Company’s guidelines and policies
with respect to risk assessment and risk management.
|
|
|
The Board has determined that the members of the Audit Committee meet the requirements for independence of Audit
Committee members under applicable SEC rules and Nasdaq Listing Rules. All of the members of our Audit Committee
also meet the requirements for financial literacy under the applicable rules and regulations of the SEC and Nasdaq. In
addition, each of Mr. Donnally, Mr. Hennessy and Ms. Williams qualify as an “audit committee financial expert,” as
such term is defined in Item 407 of Regulation S-K.
|
|
|
Compensation Committee
|
|
|
Chair:
|
Bruce Brown
|
|
Members:
|
James O. Donnally and Dan Hennessy
|
|
Meetings Held in 2024:
|
1
|
|
Committee Description and Responsibilities:
|
|
|
The Compensation Committee is responsible for determining our general compensation policies and the compensation
provided to our officers. The Compensation Committee’s other responsibilities include annually reviewing and making
recommendations to our Board regarding director compensation, reviewing and administering equity and non-equity
incentive compensation and other plans, reviewing and approving all grants, awards, and payouts under the Company’s
equity and other-incentive based plans, and overseeing our corporate compensation programs.
|
|
|
The Board has determined that each member of our Compensation Committee is independent, as defined under the
Nasdaq Listing Rules, and also satisfies Nasdaq’s additional independence standards for compensation committee
members. Other than Jim Donnally, each member of our Compensation Committee is a non-employee director (within
the meaning of Rule 16b-3 under the Exchange Act).
|
|
|
N&CG Committee
|
|
|
Chair:
|
Michael Amalfitano
|
|
Members:
|
Bruce Brown and Elizabeth Williams
|
|
Meetings Held in 2024:
|
1
|
|
Committee Description and Responsibilities:
|
|
|
The N&CG Committee assists the Board in establishing corporate governance guidelines, overseeing the Board’s
operations and effectiveness, and identifying, screening, and recommending to the Board qualified candidates to serve
as directors of the Company. The N&CG Committee is responsible for making recommendations to our Board
regarding candidates for directorships, the size and composition of the Board, and recommending an independent
director to serve as a LID, if necessary. In addition, the N&CG Committee is responsible for periodically evaluating our
corporate governance process, reporting and making recommendations to the Board concerning corporate governance
matters, adopting a performance review process for formal evaluation of the Board and Board committees, and
periodically reviewing and recommending to the Board changes to the documents and policies in the Company’s
corporate governance framework.
|
|
|
The Board has determined that each member of our N&CG Committee is independent as defined under the Nasdaq
Listing Rules.
|
|
|
Fiscal Year Ended
December 31,
|
||||
|
Company Name
|
2024
|
2023
|
||
|
Accelsius
.....................................................................................................................
|
$
126
|
160
|
||
|
AeroFlexx
...................................................................................................................
|
*
|
*
|
||
|
ESG Fund
...................................................................................................................
|
*
|
*
|
||
|
Refinity
.......................................................................................................................
|
$
539
|
*
|
||
|
2024
|
2023
|
|||
|
Audit Fees
(1)
...............................................................................................................
|
$
981,547
|
$
400,903
|
||
|
Audit-Related Fees
....................................................................................................
|
—
|
—
|
||
|
Tax Fees
.....................................................................................................................
|
—
|
—
|
||
|
All Other Fees
(2)
.........................................................................................................
|
108,387
|
—
|
||
|
Total Fees
..................................................................................................................
|
$
1,089,934
|
$
400,903
|
|
Assumed Sale Price per Share
|
Maximum Shares of Common Stock Issuable Under the SEPA
|
|
|
$3.00
|
25,000,000
|
|
|
$4.00
|
18,750,000
|
|
|
$5.00
|
15,000,000
|
|
|
$6.00
|
12,500,000
|
|
|
$7.00
|
10,714,285
|
|
|
$8.00
|
9,375,000
|
|
|
$9.00
|
8,333,333
|
|
|
$10.00
|
7,500,000
|
|
Assumed Conversion Price
|
Common Stock Issuable Upon Conversion of Convertible Debentures
|
|
|
$3.00
|
10,000,000
|
|
|
$4.00
|
7,500,000
|
|
|
$5.00
|
6,000,000
|
|
|
$6.00
|
5,000,000
|
|
|
$7.00
|
4,285,714
|
|
|
$8.00
|
3,750,000
|
|
|
$9.00
|
3,333,333
|
|
|
$10.00
|
3,000,000
|
|
Name and Principal
Position
|
Fiscal
Year
|
Salary
($)(1)
|
Bonus
($)(2)
|
Stock
Awards
($)(3)
|
Option
Awards
($)(4)
|
Non-Equity
Incentive Plan
Compensation
($)
|
All Other
Compensation
($)(5)
|
Total ($)
|
||||||||
|
Gregory W. (Bill) Haskell
.......
|
2024
|
300,000
|
2,500,000
|
—
|
—
|
—
|
13,800
|
2,813,800
|
||||||||
|
Chief Executive
Officer
.................................
|
2023
|
300,000
|
180,000
|
—
|
—
|
—
|
12,000
|
492,000
|
||||||||
|
Mike Otworth
..........................
|
2024
|
300,000
|
—
|
7,001,001
|
7,577,786
|
—
|
—
|
14,878,787
|
||||||||
|
Executive
Chairman(6)
........................
|
2023
|
300,000
|
180,000
|
—
|
—
|
—
|
—
|
480,000
|
||||||||
|
Dr. John Scott
..........................
|
2024
|
300,000
|
—
|
4,100,005
|
6,935,489
|
—
|
—
|
11,335,494
|
||||||||
|
Chief Strategy
Officer(7)
............................
|
2023
|
300,000
|
180,000
|
—
|
—
|
—
|
—
|
480,000
|
|
NEO
|
2024 Base Salary/
Service Fee Rate
|
|
|
Gregory Haskell
.......................................................................................................
|
$300,000
|
|
|
Mike Otworth
...........................................................................................................
|
$300,000
|
|
|
Dr. John Scott
..........................................................................................................
|
$300,000
|
|
2024 Bonus Goal
|
Weighting
|
Goal Achieved?
(yes or no)
|
|
Formation of a new (4th) operating company
|
25%
|
Yes
|
|
Complete the Business Combination with more than $20 million of net
proceeds
|
50%
|
Yes
|
|
Meeting each of the following milestones (or a achieving a certain threshold share price):
|
||
|
•
Formation of a new (4th) operating company
|
10%
|
Yes
|
|
•
$10 million of booked revenue for Accelsius
|
10%
|
No
|
|
•
$15 million of GAAP revenue for AeroFlexx
|
5%
|
No
|
|
NEO
|
RSUs
|
Options*
|
||
|
Gregory Haskell
.........................................................................................................
|
—
|
—
|
||
|
Mike Otworth
............................................................................................................
|
537,705
|
262,295
|
||
|
Dr. John Scott
............................................................................................................
|
336,066
|
163,934
|
|
Name
|
Grant
Date
|
Number of
securities
underlying
the award
|
Exercise price of
the award ($/Sh)
|
Grant date fair
value of the
award
|
Percentage change in the
closing market price of
the securities underlying
the award between the
trading day ending
immediately prior to the
disclosure of material
nonpublic information
and the trading day
beginning immediately
following the disclosure
of material nonpublic
information
|
|||||
|
Gregory Haskell,
CEO
..............................
|
—
|
—
|
—
|
—
|
—
|
|||||
|
Mike Otworth,
Executive Chairman
.....
|
12/9/2024
|
|
|
$
|
(
|
|||||
|
Dr. John Scott,
Chief Strategy Officer
..
|
12/9/2024
|
|
|
$
|
(
|
|
Option Awards
|
Stock Awards
|
||||||||||||||||
|
Name
|
Type of
Award(1)
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
Option
Exercise Price
($)
|
Option
Expiration
Date
|
Number of
Shares or Units
of Stock That
Have Not
Vested (#)
|
Market Value
of Shares or
Units of Stock
That Have Not
Vested ($)
|
||||||||||
|
Gregory W. (Bill)
Haskell
.............................
|
Refinity Units
|
—
|
—
|
—
|
—
|
109,000
|
(4)
|
0
|
|||||||||
|
Mike Otworth
.................
|
INV Options
|
—
|
262,295
|
(2)
|
12.20
|
12/9/2034
|
|||||||||||
|
Refinity Units
|
109,000
|
(4)
|
0
|
||||||||||||||
|
Accelsius SARs
|
—
|
150,000
|
(3)
|
12.18
|
12/31/2026
|
||||||||||||
|
INV RSUs
|
537,705
|
(5)
|
7,447,214
|
||||||||||||||
|
Accelsius Units
|
75,000
|
(6)
|
3,147,750
|
(7)
|
|||||||||||||
|
Dr. John Scott
.................
|
INV Options
|
—
|
163,934
|
(2)
|
12.20
|
12/9/2034
|
|||||||||||
|
Refinity Units
|
109,000
|
(4)
|
0
|
||||||||||||||
|
Accelsius SARs
|
—
|
150,000
|
(3)
|
12.18
|
12/31/2026
|
||||||||||||
|
INV RSUs
|
336,066
|
(5)
|
4,654,514
|
||||||||||||||
|
Accelsius Units
|
—
|
—
|
—
|
—
|
9,375
|
(8)
|
434,813
|
(7)
|
|||||||||
|
Name
|
Fees earned or paid
in cash ($)
|
Stock awards ($)(1)
|
Option awards
($)(2)
|
Total ($)
|
||||
|
James Donnally
.........
|
27,500
|
89,999
|
782,000
|
899,499
|
||||
|
Bruce Brown
.............
|
27,500
|
89,999
|
—
|
117,499
|
||||
|
Elizabeth Williams
...
|
25,000
|
89,999
|
—
|
114,999
|
||||
|
Daniel Hennessy
........
|
25,000
|
89,999
|
—
|
114,999
|
||||
|
Michael Amalfitano
..
|
25,000
|
89,999
|
—
|
114,999
|
|
Name and Address of Beneficial Owner
|
Amount and Nature of
Beneficial Ownership
|
Percentage of
Outstanding Shares
|
||
|
Directors and Named Executive Officers:
|
||||
|
Roland Austrup
...................................................................................
|
863,264
|
1.61%
|
||
|
James O. Donnally
(1)
...........................................................................
|
4,224,536
|
7.90%
|
||
|
Gregory W. Haskell
............................................................................
|
752,115
|
1.41%
|
||
|
Michael Otworth
(2)
..............................................................................
|
2,942,902
|
5.50%
|
||
|
John Scott
(3)
.........................................................................................
|
2,081,653
|
3.89%
|
||
|
David Yablunosky
..............................................................................
|
185,871
|
*
|
||
|
Suzanne Niemeyer
..............................................................................
|
153,005
|
*
|
||
|
Bruce Brown
.......................................................................................
|
—
|
*
|
||
|
Elizabeth Williams
..............................................................................
|
—
|
*
|
||
|
Daniel J. Hennessy
..............................................................................
|
1,170,262
|
2.19%
|
||
|
Michael Amalfitano
............................................................................
|
—
|
*
|
||
|
All Directors and Executive Officers as a Group (11 Individuals)
.....
|
12,373,608
|
23.13%
|
||
|
Five Percent Holders
|
||||
|
WE-INN LLC
(4)
..................................................................................
|
9,235,795
|
17.27%
|
||
|
Ascent X Innventure TC, A Series of Ascent X Innventure, LP
(5)
.....
|
3,541,685
|
6.59%
|
||
|
CastleKnight Master Fund LP
(6)
..........................................................
|
3,953,354
|
7.39%
|
||
|
Glockner Family Venture Fund, LP
(7)
................................................
|
4,680,272
|
8.75%
|
|
Plan Category
|
Number of securities to be
issued upon exercise of
outstanding options,
warrants
and rights(1)(a)
|
Weighted-average exercise
price of outstanding
options, warrants and
rights(2)(b)
|
Number of securities
remaining
available for future issuance
under
equity compensation plans
(excluding securities
reflected in
column (a))(3)(c)
|
|||
|
Equity compensation plans approved by
security holders
............................................
|
3,878,195
|
$12.20
|
7,144,699
|
|||
|
Equity compensation plans not approved by
security holder
.............................................
|
—
|
—
|
—
|
|||
|
TOTAL
............................................................
|
3,878,195
|
$12.20
|
7,144,699
|
|
By Order of the Board of Directors
|
||
|
Suzanne Niemeyer
Corporate Secretary
May 9, 2025
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|